Pharmaceuticals
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
A Johnson & Johnson building is shown in Irvine, California. Mike Blake | Reuters Johnson & Johnson on Wednesday said it’s ducking out of the RSV vaccine race, weeks after competitors Pfizer and GSK inched closer to launching the world’s first shot against the deadly virus. J&J will stop working on its investigational RSV adult […]
Read More
Carl Icahn wants to bring back Illumina’s ex-CEO ‘immediately’ as proxy fight intensifies
Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Wednesday said Illumina should bring back its former CEO “immediately,” his latest move in a brewing proxy fight with the biotech company. Icahn said in an interview with the Wall Street Journal that the […]
Read More
U.S. baby formula supply is still vulnerable, former FDA official tells lawmakers
Frank Yiannas, former deputy commissioner of the office of food policy and response at the Food and Drug Administration (FDA), speaks during a House Oversight and Accountability Subcommittee hearing in Washington, DC, on Tuesday, March 28, 2023. Ting Shen | Bloomberg | Getty Images The U.S. supply of infant formula industry is still vulnerable to […]
Read More
With travel nurses making $150 an hour, hospital systems are forced to innovate
Cassie Jupin grew up wanting to be a nurse. She set her sights on a job at St. Peter’s Health Partners hospital in Albany, New York, and landed a position in the same maternity ward where she was born. “Knowing that I can come back to work every single day and work with a group […]
Read More
Labcorp to pay $2.1 million to settle DOJ lawsuit for allegedly overbilling Defense Department
Laboratory Corporation of America will pay the U.S. $2.1 million to settle allegations that it overbilled the Department of Defense for genetic tests that involved children and fetuses, the Justice Department announced Monday. A former LabCorp employee turned whistleblower, Donna Hecker-Gross, sued the diagnostic testing company in 2018 on behalf of the federal government under […]
Read More
BioNTech shares slip on gloomy Covid vaccine sales outlook
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Shares of BioNTech on Monday slid by more than 6% in morning trading after the German drugmaker shared a gloomy 2023 sales outlook for its […]
Read More
Wyoming abortion ban blocked due to Obamacare-era amendment
Abortion is legal in Wyoming again, oddly enough as the result of a state constitutional amendment pushed by conservatives opposed to Obamacare more than a decade ago. Teton County District Court Judge Melissa Owens in a ruling Wednesday temporarily blocked enforcement of the state’s newly enacted abortion ban that took effect Sunday. Owens’ decision pointed […]
Read More
View reside: President Biden addresses the Canadian Parliament
(The stream is slated to start out at 2 p.m. ET. You should refresh the web page if you do not see a video clip previously mentioned at that time.) President Joe Biden will handle Canada’s Parliament on Friday afternoon as he appears to be to strengthen bonds among the two nations amid quite a […]
Read More
Carl Icahn claims Illumina directors got extra insurance to close ‘disastrous’ $7.1 billion Grail deal
Carl Icahn on Friday alleged that Illumina‘s directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of cancer test developer Grail in 2021. The claim is the latest development in a brewing proxy fight between the activist investor and San Diego-based Illumina, who have been trading jabs […]
Read More
Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says
A prescription for Pfizers Paxlovid tablets outside of his apartment in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post) Rachel Wisniewski | The Washington Post | Getty Images People who take Pfizer‘s Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their […]
Read More